Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal compartments
US4731360A · kind A · utility
20Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 16, 1985 |
| Grant date | Mar 15, 1988 |
| Priority date | — |
| Expiry date | Aug 16, 2005 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/006
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Acylcarnitine used as a nasal, buccal, sublingual and vaginal drug absorption enhancing vehicle for poorly absorbed drugs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.